Premium
Video‐Assisted Thoracoscopic Implantation of the Left Ventricular Pacing Lead for Cardiac Resynchronization Therapy
Author(s) -
JUTLEY RAJWINDER S.,
WALLER DAVID A.,
LOKE IAN,
SKEHAN DOUGLAS,
NG ANDRE,
STAFFORD PETER,
CHIN DEREK,
SPYT T. J.
Publication year - 2008
Publication title -
pacing and clinical electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 101
eISSN - 1540-8159
pISSN - 0147-8389
DOI - 10.1111/j.1540-8159.2008.01095.x
Subject(s) - medicine , cardiac resynchronization therapy , coronary sinus , ventricle , cardiology , lead (geology) , ischemic cardiomyopathy , surgery , heart failure , ejection fraction , geomorphology , geology
Background: To study the feasibility and efficacy of video‐assisted thoracoscopic (VAT) placement of the left ventricular pacing lead for cardiac resynchronization therapy (CRT) where the conventional transvenous coronary sinus approach has failed.Methods: Seventeen patients underwent the VAT procedure. Indications for CRT were ischemic cardiomyopathy in six patients and nonischemic cardiomyopathy in 11. The procedure was performed under general anesthesia with single‐lung ventilation. Three 2‐cm incisions were used on the left chest wall to place the screw‐in lead near the obtuse marginal arteries high on the lateral wall of the left ventricle (LV).Results: The VATS approach was successful in 13/17 (76%) patients. Median procedure time was 75 minutes (range 55–135). A learning curve was observed that appeared to plateau at 75 minutes procedure time after four cases. Median length of hospital stay was 2 days (range 2–8) with one patient requiring intensive care. Satisfactory thresholds and impedances of 2.3 ± 0.9 V/0.5 ms and 560 ohms, respectively, were achieved at mean follow‐up of 226 days. All patients reported symptomatic benefit with reduction in New York Heart Association score from III preoperatively to II postoperatively.Conclusions: VAT placement of the epicardial pacing lead is feasible, safe, and efficacious. It should be considered in cases where the transvenous route has failed or as an alternative in prolonged or hazardous transvenous procedures.